![Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825811009735-fx2.jpg)
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect
![A label-free dual immunosensor for the simultaneous electrochemical determination of CA125 and HE4 biomarkers for the early diagnosis of ovarian cancer | SpringerLink A label-free dual immunosensor for the simultaneous electrochemical determination of CA125 and HE4 biomarkers for the early diagnosis of ovarian cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00216-023-04569-y/MediaObjects/216_2023_4569_Figa_HTML.png)
A label-free dual immunosensor for the simultaneous electrochemical determination of CA125 and HE4 biomarkers for the early diagnosis of ovarian cancer | SpringerLink
![PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. | Semantic Scholar PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7968dca1873e681e0be5dd4a14690d730da0e0b2/4-Table2-1.png)
PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. | Semantic Scholar
![Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response – topic of research paper in Veterinary science. Download scholarly article PDF and read Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response – topic of research paper in Veterinary science. Download scholarly article PDF and read](https://cyberleninka.org/viewer_images/960103/f/1.png)
Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response – topic of research paper in Veterinary science. Download scholarly article PDF and read
![Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download](https://slideplayer.com/slide/6626598/23/images/3/Introduction+%28cont%E2%80%99d%29.jpg)
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download
![Table 2 from Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar Table 2 from Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f50dc44db73d02a0fdaecab49c845d96479f6e8f/3-Table2-1.png)
Table 2 from Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar
![Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download](https://slideplayer.com/slide/6626598/23/images/4/Questions+Is+HE4+a+specific+tumor+marker.jpg)
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download
![A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//18075932/0000006700000005/v1_202212011555/S1807593222018178/v1_202212011555/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNfuNpdT3pEXC7tmqfbE1Y0Z1p9+vAlVDCDNpqpxHzzp8Z0ILrOhT7YePrkmPFgJXhRefw4ABU3JKFsav571eCDEBUhjI79Bed2vwyg+06u15e5p0zEc7NR8pKOODemQ8Jl7shbpnR5Z7fS6msjciMc9exfReX6xEt3CpsUcLrQq2+COvxzN0YvO0v9diCVzdtXH5DjBo0uguSf7DejoHnqvOJgN9DgkVeQr5ZRPIsThWOr2uAw3C2JxlJ7ad8KbJ5A=)
A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics
![Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1e28ef43-c740-4fed-8a87-890cd2491360/ntbl004.jpg)